Trial Details

Not Recruiting
Basic Information
Clinical ID c2985
Identifier JPRN-UMIN000018975
Trial Title A Study of Immunogenicity and Efficacy by quadrivalent Influenza Vaccination in Inflammatory Bowel Disease Patients - Efficacy of Influenza Vaccination in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Inflammatory bowel disease
Interventions Serum antibody titers obtained prior to vaccination and 4~6 weeks after the first and second dose of quadrivalent influenza vaccine were tested to Inflammatory bowel disease patients, and efficacy were reported. Serum antibody titers obtained prior to vaccination and 4~6 weeks after the first and second dose of quadrivalent influenza vaccine were tested to healthy adults, and efficacy were reported.
Participant Information
Sponsor Saga University Hospital
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement INFANT
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2016-08-31